• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医用大麻患者将大麻用于娱乐目的的流行情况和相关因素。

Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.

机构信息

Oberlin College, Department of Psychology, 120 West Lorain Street, Oberlin, OH 44074, USA.

出版信息

Addict Behav. 2019 Jun;93:233-239. doi: 10.1016/j.addbeh.2019.02.003. Epub 2019 Feb 7.

DOI:10.1016/j.addbeh.2019.02.003
PMID:30772776
Abstract

BACKGROUND

Rates of legal medical cannabis (MC) use are increasing, but little is known about the prevalence and correlates of recreational cannabis (RC) use among medical users (MC/R).

METHODS

348 MC users who resided in a state in which MC is legal and had medical authorization to use MC legally completed an anonymous survey in Spring 2017 (64.1% female, 82.8% White, mean age 33.03[±10.37] years). Rates of endorsing MC/R and the following potential correlates of MC/R were examined: the legal status of RC in participants' states of residence, sex, age, race, primary medical condition, MC product(s) used, MC expectancies, features of MC sought out (e.g., high tetrahydrocannabinol [THC] content), and negative cannabis use consequences.

RESULTS

55.5% of MC users engaged in MC/R. MC/R was associated with residing in a state in which RC is legal, being female, using MC for pain or mental health conditions, vaping MC concentrates, holding positive expectancies for combustible MC, and seeking out MC products with high THC concentrations. Preferring MC products with high cannabidiol (CBD) concentrations protected against MC/R.

CONCLUSIONS

More than half of MC users endorsed MC/R, which is considerably higher than rates of misuse observed for other prescription medications. Findings raise concerns about circumvention of RC laws in states where RC remains illegal and could be used to inform MC regulatory efforts (e.g., reducing THC content, increasing CBD content). Findings also suggest that prevention/intervention efforts to reduce MC/R are needed, especially among high-risk populations of MC users (e.g., women, pain patients, psychiatric patients).

摘要

背景

合法医用大麻(MC)的使用率正在上升,但人们对医用大麻使用者(MC/R)中娱乐性大麻(RC)使用的流行率和相关因素知之甚少。

方法

2017 年春季,348 名居住在医用大麻合法且有合法使用医用大麻授权的州的 MC 用户完成了一项匿名调查(64.1%为女性,82.8%为白人,平均年龄为 33.03[±10.37]岁)。检查了支持 MC/R 的比率以及 MC/R 的以下潜在相关因素:参与者居住州 RC 的法律地位、性别、年龄、种族、主要医疗状况、使用的 MC 产品、MC 预期、寻求的 MC 特征(例如,高四氢大麻酚[THC]含量)以及负面的大麻使用后果。

结果

55.5%的 MC 用户从事 MC/R。MC/R 与居住在 RC 合法的州、女性、因疼痛或心理健康状况使用 MC、吸食 MC 浓缩物、对可燃 MC 持有积极预期以及寻求高 THC 浓度的 MC 产品有关。偏爱高大麻二酚(CBD)浓度的 MC 产品可预防 MC/R。

结论

超过一半的 MC 用户支持 MC/R,这明显高于其他处方药滥用的比率。这些发现引起了人们对在 RC 仍然非法的州规避 RC 法律的关注,并可用于为 MC 监管工作提供信息(例如,降低 THC 含量,增加 CBD 含量)。研究结果还表明,需要采取预防/干预措施来减少 MC/R,特别是针对高风险的 MC 用户群体(例如,女性、疼痛患者、精神疾病患者)。

相似文献

1
Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.医用大麻患者将大麻用于娱乐目的的流行情况和相关因素。
Addict Behav. 2019 Jun;93:233-239. doi: 10.1016/j.addbeh.2019.02.003. Epub 2019 Feb 7.
2
The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.大麻( marijuana )和大麻二酚( CBD )在美国法律下的法律地位。
Epilepsy Behav. 2017 May;70(Pt B):288-291. doi: 10.1016/j.yebeh.2016.11.021. Epub 2017 Feb 4.
3
Mapping cannabis potency in medical and recreational programs in the United States.绘制美国医疗和娱乐用大麻效力图。
PLoS One. 2020 Mar 26;15(3):e0230167. doi: 10.1371/journal.pone.0230167. eCollection 2020.
4
Factors Associated with Medical Cannabis Use After Certification: A Three-Month Longitudinal Study.与医疗大麻使用相关的因素:一项为期三个月的纵向研究。
Cannabis Cannabinoid Res. 2024 Jun;9(3):e859-e869. doi: 10.1089/can.2022.0248. Epub 2023 Mar 24.
5
Marijuana use among patients with epilepsy at a tertiary care center.癫痫患者在三级护理中心使用大麻的情况。
Epilepsy Behav. 2019 Aug;97:144-148. doi: 10.1016/j.yebeh.2019.05.037. Epub 2019 Jun 25.
6
Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.不同大麻素产品成分的处方医用大麻使用差异:来自 2020 年澳大利亚全国医用大麻调查(CAMS-20)的研究结果。
PLoS One. 2024 Feb 14;19(2):e0297092. doi: 10.1371/journal.pone.0297092. eCollection 2024.
7
The impacts of potency, warning messages, and price on preferences for Cannabis flower products.效力、警示信息和价格对大麻花产品偏好的影响。
Int J Drug Policy. 2019 Dec;74:1-10. doi: 10.1016/j.drugpo.2019.07.037. Epub 2019 Aug 2.
8
Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.加利福尼亚州药房提供的草药大麻产品中四氢大麻酚含量与价格的关联性:消费者/患者视角。
Front Public Health. 2022 Jun 17;10:893009. doi: 10.3389/fpubh.2022.893009. eCollection 2022.
9
Patterns and correlates of cannabidiol product and marijuana co-use in a sample of U.S. young adults.在美国青年成年人样本中,大麻二酚产品和大麻共同使用的模式和相关性。
Addict Behav. 2022 Mar;126:107185. doi: 10.1016/j.addbeh.2021.107185. Epub 2021 Nov 20.
10
Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.洛杉矶大麻使用者中年轻人的大麻素(CBD)和其他药物使用情况。
Drug Alcohol Depend. 2021 Apr 1;221:108648. doi: 10.1016/j.drugalcdep.2021.108648. Epub 2021 Feb 22.

引用本文的文献

1
Cannabis Use Characteristics and Reasons for Product Choices Among Patients Accessing Treatment for Substance Use Disorders: A Mixed-Methods Study.物质使用障碍患者接受治疗期间的大麻使用特征及产品选择原因:一项混合方法研究
Cannabis. 2025 Jul 15;8(2):67-84. doi: 10.26828/cannabis/2025/000309. eCollection 2025.
2
Pain Intensity and Hazardous Cannabis Use: The Moderating Role of Pain-related Anxiety.疼痛强度与危险的大麻使用:疼痛相关焦虑的调节作用。
J Psychoactive Drugs. 2025 Jun 10:1-8. doi: 10.1080/02791072.2025.2511756.
3
Predictors of medical and non-medical motives of cannabis use in Finland: A cross-sectional survey study.
芬兰大麻使用的医学和非医学动机的预测因素:一项横断面调查研究。
iScience. 2025 Apr 22;28(5):112503. doi: 10.1016/j.isci.2025.112503. eCollection 2025 May 16.
4
Patterns of cannabidiol use among marijuana users in the United States.美国大麻使用者中使用大麻二酚的模式。
Prev Med Rep. 2025 Jan 20;50:102985. doi: 10.1016/j.pmedr.2025.102985. eCollection 2025 Feb.
5
Characteristics of patients with non-cancer pain and long-term prescription opioid use who have used medical versus recreational marijuana.使用医用大麻与消遣性大麻的非癌性疼痛患者及长期处方阿片类药物使用者的特征。
J Cannabis Res. 2024 Feb 22;6(1):7. doi: 10.1186/s42238-024-00218-y.
6
Health, safety, and socioeconomic impacts of cannabis liberalization laws: An evidence and gap map.大麻合法化法律对健康、安全及社会经济的影响:证据与差距图谱
Campbell Syst Rev. 2023 Oct 30;19(4):e1362. doi: 10.1002/cl2.1362. eCollection 2023 Dec.
7
Cannabis use among workers with work-related injuries and illnesses: results from a cross-sectional study of workers' compensation claimants in Ontario, Canada.工人因工作相关伤和病使用大麻的情况:安大略省工人赔偿索赔者的横断面研究结果。
BMJ Open. 2023 Jul 18;13(7):e072994. doi: 10.1136/bmjopen-2023-072994.
8
The Cannabis Effects Expectancy Questionnaire-Medical (CEEQ-M): Preliminary psychometric properties and longitudinal validation within a clinical trial.《大麻效应预期问卷-医疗版》(CEEQ-M):临床试验中的初步心理测量特性和纵向验证。
Psychol Assess. 2023 Aug;35(8):659-673. doi: 10.1037/pas0001244. Epub 2023 Jun 8.
9
The association between cannabis use and risk of non-medical pain reliever misuse onset among young adults in a legal cannabis context.在合法大麻环境下,大麻使用与年轻人非医疗性止痛药滥用起始之间的关联。
Addict Behav. 2023 Aug;143:107711. doi: 10.1016/j.addbeh.2023.107711. Epub 2023 Mar 30.
10
Egocentric Network Characteristics and Cannabis Use in a Sample of Young Adult Medical Cannabis Patients and Nonpatient Users.以自我为中心的网络特征与年轻成人医用大麻患者和非患者使用者中的大麻使用情况。
J Stud Alcohol Drugs. 2022 Nov;83(6):802-811. doi: 10.15288/jsad.21-00286.